Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$915,593
+$685,829 QoQ
Shares Held
6,950
+329.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$425,850
PutShares
5,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CSS LLC/IL holds $5,129,429 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (17.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
2,757 | $1,634,845 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
6,950 | $915,593 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
27,070 | $815,348 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
37,616 | $780,908 | |
| 5 | ZTS |
Zoetis Inc.
|
6,220 | $735,266 | |
| 6 | VTRS |
Viatris Inc
|
8,520 | $115,105 | |
| 7 | YCBD |
cbdMD, Inc.
|
137,621 | $102,114 | |
| 8 | EVO |
Evotec SE
|
12,100 | $30,250 |
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $915,593 | 6,950 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $229,764 | 1,620 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $300,832 | 2,720 | Shares | Sole | 2025-05-15 | |
| 2021-12-31 | $425,850 | 5,000 | Put | Sole | 2022-02-14 | |
| 2020-03-31 | $8,655 | 100 | Put | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||